New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data
- FDA Approval Based on Updated Results Showing a 20% Reduction in the Risk of Death at Six Years and a 22% Improvement of Disease Free Survival at Five Years, For Stage III Colon Cancer, Post Surgery -<img src="http://feeds.foxbusiness.com/~r/foxbusiness/latest/~4/299617997" height="1" width="1"/><img src="http://feeds.foxnews.com/~r/foxnews/business/~4/299620577" height="1" width="1"/>
http://feeds.foxnews.com/~r/foxnews/business/~3/299620577/